Style | Citing Format |
---|---|
MLA | Karami F, et al.. "Bioinformatics Prediction and in Vitro Analysis Revealed That Mir-17 Targets Cyclin D1 Mrna in Triple Negative Breast Cancer Cells." Chemical Biology and Drug Design, vol. 87, no. 3, 2016, pp. 317-320. |
APA | Karami F, Mohammadiyeganeh S, Abedi N, Koochaki A, Kia V, Paryan M (2016). Bioinformatics Prediction and in Vitro Analysis Revealed That Mir-17 Targets Cyclin D1 Mrna in Triple Negative Breast Cancer Cells. Chemical Biology and Drug Design, 87(3), 317-320. |
Chicago | Karami F, Mohammadiyeganeh S, Abedi N, Koochaki A, Kia V, Paryan M. "Bioinformatics Prediction and in Vitro Analysis Revealed That Mir-17 Targets Cyclin D1 Mrna in Triple Negative Breast Cancer Cells." Chemical Biology and Drug Design 87, no. 3 (2016): 317-320. |
Harvard | Karami F et al. (2016) 'Bioinformatics Prediction and in Vitro Analysis Revealed That Mir-17 Targets Cyclin D1 Mrna in Triple Negative Breast Cancer Cells', Chemical Biology and Drug Design, 87(3), pp. 317-320. |
Vancouver | Karami F, Mohammadiyeganeh S, Abedi N, Koochaki A, Kia V, Paryan M. Bioinformatics Prediction and in Vitro Analysis Revealed That Mir-17 Targets Cyclin D1 Mrna in Triple Negative Breast Cancer Cells. Chemical Biology and Drug Design. 2016;87(3):317-320. |
BibTex | @article{ author = {Karami F and Mohammadiyeganeh S and Abedi N and Koochaki A and Kia V and Paryan M}, title = {Bioinformatics Prediction and in Vitro Analysis Revealed That Mir-17 Targets Cyclin D1 Mrna in Triple Negative Breast Cancer Cells}, journal = {Chemical Biology and Drug Design}, volume = {87}, number = {3}, pages = {317-320}, year = {2016} } |
RIS | TY - JOUR AU - Karami F AU - Mohammadiyeganeh S AU - Abedi N AU - Koochaki A AU - Kia V AU - Paryan M TI - Bioinformatics Prediction and in Vitro Analysis Revealed That Mir-17 Targets Cyclin D1 Mrna in Triple Negative Breast Cancer Cells JO - Chemical Biology and Drug Design VL - 87 IS - 3 SP - 317 EP - 320 PY - 2016 ER - |